ImmuneMed
Latest round
- Series C
Last raised
- Mar 2019
Total raised
- $25M
Investors
- 8
About ImmuneMed
Founded in 2000 and based in Chuncheon, South Korea, ImmuneMed Inc. operates as a biopharmaceutical company that researches and develops antiviral agents. The company also produces diagnostic kits for infectious diseases. In June 2023, ImmuneMed Inc.6 billion post-money.
Who invested in ImmuneMed
8 investors across 3 rounds
See all investors in ImmuneMed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ImmuneMed
Who invested in ImmuneMed?
ImmuneMed has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ImmuneMed raised?
ImmuneMed has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did ImmuneMed last raise money?
ImmuneMed's most recent round on record is a Series C, in Mar 2019.
What does ImmuneMed do?
Founded in 2000 and based in Chuncheon, South Korea, ImmuneMed Inc.
Where is ImmuneMed headquartered?
ImmuneMed is headquartered in Chuncheon, South Korea.
Which VCs invest in companies like ImmuneMed?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ImmuneMed's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like ImmuneMed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.